The Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey

The Rutgers Cancer Institute of New Jersey is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

The Rutgers Cancer Institute of New Jersey has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Kidney Cancer, Renal Cell Carcinoma.

Sponsors: Mark Stein.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Rutgers Cancer Institute of New Jersey?

The Rutgers Cancer Institute of New Jersey has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Rutgers Cancer Institute of New Jersey conducted?

The Rutgers Cancer Institute of New Jersey has 1 clinical trials on record, with 1 currently active. Their work covers Kidney Cancer, Renal Cell Carcinoma.

Is The Rutgers Cancer Institute of New Jersey accredited by Crixeo Health?

The Rutgers Cancer Institute of New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Rutgers Cancer Institute of New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.